Delivery Order SPE2DB24D9238-SPE2DB24FDQJH
Award Date
6/25/24
Potential Completion Date
7/17/24
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $2,003.02 contract is for the supply of OZURDEX 0.7 MG IMPLANTS, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. The contract is part of DMS Pharmaceutical Group's broader indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $4,006.04 and is for the delivery of OZURDEX 0.7 MG IMPLANTS to support the recurring medical supply needs of military health facilities. The contract has a period of performance through May 9, 2024 and does not have a set-aside designation. This delivery order contract is part of a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of OZURDEX 0.7 MG IMPLANTS, with a potential value of $3,004.53 and a completion date of March 7, 2024. This delivery order is likely part of DMS Pharmaceutical Group's broader indefinite delivery contract with DLA, contract 4600082013 under the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,004.53, is for the delivery of OZURDEX 0.7 MG IMPLANTS to support the recurring pharmaceutical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of OZURDEX 0.7 MG IMPLANTS. The total potential value of the contract is $3,004.53, with a period of performance through April 10, 2024. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Vehicle (IDV) contract, SPE2DB, with the DLA valued at up to $4,999,999 through the end of 2025. This IDV enables the DLA to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $2,003.02 contract is for the delivery of OZURDEX 0.7 MG IMPLANTS, a pharmaceutical product. This delivery order is placed against DMS Pharmaceutical Group's larger $4,999,999 indefinite delivery contract with DLA, which enables the agency to issue orders for a broad range of pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,003.02 award is for the delivery of 0.7 mg OZURDEX implants. This order is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which provides a comprehensive range of pharmaceutical items to military health facilities worldwide. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,004.53 firm fixed-price contract is for the delivery of OZURDEX 0.7 MG IMPLANTS to support the recurring medical supply needs of military health facilities. This contract is not set aside and is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,010.76 contract is for the delivery of OZURDEX 0.7 MG IMPLANTS to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,010.76, is for the delivery of OZURDEX 0.7 MG IMPLANTS, a specialized pharmaceutical product. The contract is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure...